<b>Results:</b> This study identified FOS-like antigen 1 (FOSL1) as a key oncogenic driver that facilitates GBM progression through a positive feedback loop with inhibitor of nuclear factor kappa-B kinase subunit alpha (<i>IKKα</i>). The gene discussed is FOSL1; the disease is glioblastoma.